What's new

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Mar 3, 2025 - 13:37
 0
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Pyzchiva, ustekinumab, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Kroger says chief McMullen quits over personal conduct

Next Article

EVs At 22.5% Share In France — Citroën e-C3 On Top

Related Posts

Human medicines European public assessment report (EPAR): Trabectedin Accord, trabectedin, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Summary of opinion: Jaypirca, 27/02/2025 Positive

Summary of opinion: Jaypirca, 27/02/2025 Positive

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0